These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Clinical case presentations. Oropharyngeal and esophageal candidiasis in HIV disease. AIDS Patient Care STDS; 1997 Feb; 11 Suppl 1():S22-5. PubMed ID: 11361748 [No Abstract] [Full Text] [Related]
7. Oral candidiasis in pediatric HIV patients. Lal S, Chussid S. N Y State Dent J; 2005 Mar; 71(2):28-31. PubMed ID: 15887466 [Abstract] [Full Text] [Related]
8. Oral plaques and dysphagia in a young man. Tully AS, Dao C. Cleve Clin J Med; 2011 Sep; 78(9):594-6. PubMed ID: 21885691 [No Abstract] [Full Text] [Related]
9. No resistance to fluconazole with short-term treatment for oral thursh. AIDS Patient Care STDS; 1996 Dec; 10(6):379. PubMed ID: 11361570 [No Abstract] [Full Text] [Related]
11. Colonization of Candida species in denture wearers with emphasis on HIV infection: a literature review. Perezous LF, Flaitz CM, Goldschmidt ME, Engelmeier RL. J Prosthet Dent; 2005 Mar; 93(3):288-93. PubMed ID: 15775931 [Abstract] [Full Text] [Related]
12. Fluconazole prophylaxis in HIV disease, revisited. Bozzette SA. Clin Infect Dis; 2005 Nov 15; 41(10):1481-2. PubMed ID: 16231261 [No Abstract] [Full Text] [Related]
13. Use of prophylactic antifungals in the immunocompromised host. Ship JA, Vissink A, Challacombe SJ. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar 15; 103 Suppl():S6.e1-14. PubMed ID: 17379157 [Abstract] [Full Text] [Related]
14. Fluconazole-resistant pseudomembranous oral candidiasis. Shetty K. Ann Pharmacother; 2006 May 15; 40(5):993. PubMed ID: 16638917 [No Abstract] [Full Text] [Related]
15. Treatment of oral candidiasis: a study to determine the clinical response of sodium benzoate compared with nystatin suspension. Moshi AH, Jorgensen AF, Pallangyo K. AIDS; 1998 Nov 12; 12(16):2237-8. PubMed ID: 9833873 [No Abstract] [Full Text] [Related]
16. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial. Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ. Clin Infect Dis; 2008 Nov 15; 47(10):1270-6. PubMed ID: 18840077 [Abstract] [Full Text] [Related]
17. Itraconazole oral solution: clinical review and experience. Kauffman CA. AIDS Patient Care STDS; 1997 Feb 15; 11 Suppl 1():S18-21. PubMed ID: 11361747 [No Abstract] [Full Text] [Related]
18. [Antifungal drug susceptibility of Candida causing oropharyngeal candidiasis in HIV infected patients]. Dieng Y, Faye-Niang MA, Ndour-Diop A, Sow PS, Dieng T, Soumare M, Bah IB, Faye O, Diop BM, Gaye O, Ndir O, Diallo S. Dakar Med; 2001 Feb 15; 46(1):4-7. PubMed ID: 15773146 [Abstract] [Full Text] [Related]